Quick Answer
Universe Pharmaceuticals INC reported Operating Income of -$2.92 billion for fiscal year 2025.
Universe Pharmaceuticals INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$2.92B | +63.6% |
| 2024 | -$8.02B | -102.2% |
| 2023 | -$3.97B | -56401.6% |
| 2022 | -$7.02M | -151.7% |
| 2021 | $13.59M | +32.6% |
| 2020 | $10.25M | +5.1% |
| 2019 | $9.75M | — |
- Universe Pharmaceuticals INC showed an increase of +63.6% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, Universe Pharmaceuticals INC’s operating income has declined by 29998.2% (from $9.75 million to -$2.92 billion).
- The most recent figure is from Universe Pharmaceuticals INC’s fiscal year 2025 report (Form 20-F), filed with the SEC on January 29, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: